(2) Our ex vivo model focused on Aβ and tau pathologies in slices, neglecting assessment of other AD-relevant markers like neuroinflammation or reactive glial cells, which increasingly have a prominent role in AD pathogenesis [99]. Here, MAPT is linked to Alzheimer disease.